↓ Skip to main content

Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development

Overview of attention for article published in Health Research Policy and Systems, August 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development
Published in
Health Research Policy and Systems, August 2018
DOI 10.1186/s12961-018-0332-y
Pubmed ID
Authors

Clarke B. Cole, Stine Trolle, Danny J. Edwards

Abstract

Major pharmaceutical companies contribute important expertise to health research and development (R&D), particularly in their ability to develop and bring pharmaceuticals to market. The Access to Medicine Index evaluates how 20 of the world's largest pharmaceutical companies are directing R&D efforts towards the needs of people living in low- and middle-income countries. In dissemination of its findings, the Index stimulates pharmaceutical companies to expand R&D activities in this direction. The Index methodology is reviewed every 2 years, most recently for the 2018 Index, to ensure their R&D activity is benchmarked against current health R&D priorities as defined by the global health community. The review is based on consensus-building processes involving global health stakeholders. In the latest review, two main changes to the methodology were made that will further deepen the Index's analysis of (1) how far companies' R&D activity aligns with global health priorities; and (2) whether companies make plans to ensure resulting innovations reach populations in need globally. These changes will be applied in the 2018 Access to Medicine Index. Importantly, the methodology review process highlighted the need for further prioritisation from the global health community, in particular to emphasise to innovators which product innovations are needed most critically to address the burden of non-communicable diseases in low- and middle-income countries. Should such prioritisations be developed, the Index can play an important role in tracking and stimulating company contributions towards them.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 16%
Student > Master 6 14%
Student > Doctoral Student 5 11%
Librarian 3 7%
Student > Ph. D. Student 3 7%
Other 6 14%
Unknown 14 32%
Readers by discipline Count As %
Business, Management and Accounting 6 14%
Social Sciences 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Medicine and Dentistry 3 7%
Economics, Econometrics and Finance 3 7%
Other 7 16%
Unknown 17 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 August 2018.
All research outputs
#7,258,445
of 23,098,660 outputs
Outputs from Health Research Policy and Systems
#818
of 1,229 outputs
Outputs of similar age
#124,120
of 331,122 outputs
Outputs of similar age from Health Research Policy and Systems
#41
of 42 outputs
Altmetric has tracked 23,098,660 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,122 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.